Literature DB >> 22156461

Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis.

Martin H Luu1, Andrew H Fischer, Thomas J Stockl, Latha Pisharodi, Christopher L Owens.   

Abstract

OBJECTIVE: To determine whether or not significant differences in the risk of malignancy exist between subgroups of atypical follicular cells in The Bethesda System for Reporting Thyroid Cytology (TBSRTC) in patients who underwent surgical resection. STUDY
DESIGN: Between 2004 and 2009, consecutive thyroid fine-needle aspirates at our institutions with a cytologic diagnosis of 'atypical follicular cells' were retrieved and subclassified using the diagnosis and diagnostic comment as: (1) atypical follicular cells with equivocal features of papillary carcinoma [cannot exclude papillary thyroid carcinoma (PTC)] and (2) atypical follicular cells, other patterns. The risks of malignancy for excised nodules were calculated and comparisons were made between these subgroups. Categorical analysis was performed using a 2-tailed Fisher's exact test, and p < 0.05 was considered statistically significant.
RESULTS: A total of 7,072 thyroid fine-needle aspiration cases were retrieved, with 1,542 (21.8%) having a histologic follow-up. There were 222 (3.1%) cases of 'atypical follicular cells', with 127 (57.2%) having a histologic correlation and 33 having confirmed malignancies. Atypical follicular cells, cannot exclude PTC, have a significantly higher risk of malignancy than atypical follicular cells, other patterns (45.8 vs. 13.9%, p < 0.01).
CONCLUSIONS: Atypical follicular cells with equivocal features of papillary carcinoma is not a low-risk cytologic diagnosis.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22156461     DOI: 10.1159/000333227

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  6 in total

1.  Indian experience of AUS/FLUS diagnosis: is it different from rest of Asia and the West?-A systematic review and meta-analysis.

Authors:  Prerna Guleria; Kalaivani Mani; Shipra Agarwal
Journal:  Gland Surg       Date:  2020-10

2.  Malignancy Rates of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cases: A Tertiary Center Study.

Authors:  S Erdogan-Durmus; H Balta; R Demirtas; A Kurt
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

3.  Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.

Authors:  Pablo Valderrabano; Laila Khazai; Zachary J Thompson; Susan C Sharpe; Valentina D Tarasova; Kristen J Otto; Julie E Hallanger-Johnson; J Trad Wadsworth; Bruce M Wenig; Christine H Chung; Barbara A Centeno; Bryan McIver
Journal:  Thyroid       Date:  2017-12-21       Impact factor: 6.568

4.  Malignancy rate of thyroid nodules defined as follicular lesion of undetermined significance and atypia of undetermined significance in thyroid cytopathology and its relation with ultrasonographic features.

Authors:  Neslihan Çuhaci; Dilek Arpaci; Rıfki Üçler; Aylin Kilic Yazgan; Gülten Kıyak; Samet Yalçin; Pamir Eren Ersoy; Gülnür Güler; Reyhan Ersoy; Bekir Çakir
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

5.  Role of Core Needle Biopsy in the Management of Atypia/Follicular Lesion of Undetermined Significance Thyroid Nodules: Comparison with Repeat Fine-Needle Aspiration in Subcategory Nodules.

Authors:  Dong Gyu Na; Hye Sook Min; Hunkyung Lee; Jae-Kyung Won; Hyo Bin Seo; Ji-Hoon Kim
Journal:  Eur Thyroid J       Date:  2015-07-15

6.  The Correlation of Age with Prognosis of Atypia of Undetermined Significance and Follicular Lesion of Undetermined Significance in Thyroid Nodules.

Authors:  Krzysztof Kaliszewski; Dorota Diakowska; Marta Rzeszutko; Beata Wojtczak; Jerzy Rudnicki
Journal:  Cancer Manag Res       Date:  2021-04-08       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.